Market Research Logo

China Pharmaceuticals and Healthcare Report Q3 2015

200 Pages BMI Research June 17, 2015 SKU: BMI5590674

BMI View: Multinational pharmaceutical companies will continue to invest and grow their presence inChina, despite the slowdown in the economy. Driving this outlook is the outperformance of thepharmaceutical sector as authorities continue to improve healthcare access through stronger medicalsubsidies and an expansion of insurance coverage. In addition, reforms in the pharmaceutical sector,including the removal of price caps, will shift the industry towards a market-based system that furtheraugments the commercial prospects.

Headline Expenditure Projections

Pharmaceuticals: CNY608.45bn (USD98.75bn) in 2014 to CNY691bn (USD110bn) by 2015; +13% inlocal currency terms and +11.5% in USD terms.

Healthcare: CNY3,594bn (USD583bn) in 2014 to CNY4,078bn (USD649bn) in 2015; +13.5% in localcurrency and +13.2% in USD terms.

Show Full Description


Show Table of Contents



China Pharmaceuticals and Healthcare Report Q3 2015

BMI Research
June 17, 2015

Pricing & Delivery

Report with 3 quarterly updates
$1,295
Report with 3 quarterly updates - 3 User License
$1,945
Report with 3 quarterly updates - 5 User License
$2,500
Report with 3 quarterly updates - Departmental/Site License
$2,995

Didn't find what you are looking for?

Let us find it for you. One of our knowledgeable research assistants will work with you to find exactly the right research to answer your questions:

US: 800.298.5699 International: +1.240.747.3093 Or leave us a message and we'll call you back!

Receive bi-weekly email alerts for new market research.



CTA Image

Download our free eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.


Download CTA

Share this report